Acucela Filed, US Offering, Removed, ACLA.RC

Clinical-stage biotech developing treatments for eye diseases.

Industry: Other

Latest Trade: ()

First Day Return:

Return from IPO:

Industry: Other

Clinical-stage biotech developing treatments for eye diseases.
more less
IPO News for Acucela
more
IPO Data
IPO File Date 12/17/2013
Offer Price
Price Range n/a
Offer Shares (mm) n/a
Deal Size ($mm) $n/a
IPO Data
IPO Date
Offer Price
Price Range n/a
Offer Shares (mm) n/a
Deal Size ($mm) $n/a
Underwriters
more
Company Data
Headquarters Seattle, WA
Founded 2002
Employees 86
Website www.acucela.com